What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand?

Drug and Alcohol Review
I G SheerinJ D Sellman

Abstract

The cost-effectiveness of hepatitis C virus (HCV) anti-viral therapy for injecting drug users (IDUs) on methadone maintenance is important because the majority have chronic infections that remain untreated. Cost-effectiveness analysis examines the costs of treatment compared with the benefits, which in this study are defined as savings in life. The cost-effectiveness of treatment for HCV infection is investigated for Mäori and non-Mäori IDUs on methadone maintenance therapy (MMT) in New Zealand. Markov models are used to model cohorts of IDUs, changes in their health states and the effects of MMT and anti-viral therapy on morbidity and mortality. Comparisons were made between conventional combination therapy (COT) and combination therapy with pegylated interferon. Sensitivity analysis is used to model cost-effectiveness of treatment under varying assumptions of progression of liver disease and compliance with treatment. The cost-effectiveness of MMT alone was estimated at 25397 dollars per life year saved (LYS) for non-Mäori men and 25035 dollars for non-Mäori women IDUs (costs and benefits discounted at 3%). The incremental effects of providing COT to all eligible patients were to save extra years of life, as well as to involv...Continue Reading

References

Jan 1, 1975·The American Journal of Drug and Alcohol Abuse·O WattersonS B Sells
Jul 1, 1982·American Journal of Public Health·G W JoeD D Simpson
Jun 1, 1995·The New England Journal of Medicine·M J TongR L Co
Jan 1, 1996·Substance Use & Misuse·J R CaplehornJ G Nisbet
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L B Seeff
Aug 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P GlueR P Clement
Dec 7, 2000·The New England Journal of Medicine·S ZeuzemM J Brunda
Dec 7, 2000·The New England Journal of Medicine·E J HeathcoteJ De Pamphilis
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A J FreemanJ M Kaldor
Nov 17, 2001·BMJ : British Medical Journal·G L Davis
Jul 10, 2003·Drug and Alcohol Review·Ian G SheerinJ Douglas Sellman
Jan 1, 1992·Drug and Alcohol Review·P D DukesB J Robinson

❮ Previous
Next ❯

Citations

Oct 1, 2006·Acta Neuropsychiatrica·Matthew L Cowan, James D Maxwell
Jan 1, 2010·ClinicoEconomics and Outcomes Research : CEOR·H JafferbhoyJf Dillon
Jul 7, 2007·The American Journal of Drug and Alcohol Abuse·Kathleen M Carroll, Bruce J Rounsaville
Feb 13, 2016·Journal of Hepatology·Natasha K MartinMatthew Hickman
Mar 27, 2013·Journal of Gastroenterology and Hepatology·Natasha K MartinMatthew Hickman
May 9, 2012·International Journal of Mental Health Nursing·Daryle DeeringChristopher M A Frampton
Nov 24, 2012·Journal of Gastroenterology and Hepatology·Adam J ViscontiMargaret E Hellard
Aug 7, 2009·Journal of Viral Hepatitis·G SroczynskiU Siebert
Jul 7, 2007·Journal of Substance Abuse Treatment·Benedikt FischerJürgen Rehm
Apr 11, 2018·Journal of the International AIDS Society·Natasha K MartinBart J A Rijnders

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Markus BackmundD Eichenlaub
Journal of Urban Health : Bulletin of the New York Academy of Medicine
Diana L SylvestreHenry Francis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Diana L Sylvestre
© 2021 Meta ULC. All rights reserved